These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17639041)

  • 1. Prognostic relevance of increased Rac GTPase expression in prostate carcinomas.
    Engers R; Ziegler S; Mueller M; Walter A; Willers R; Gabbert HE
    Endocr Relat Cancer; 2007 Jun; 14(2):245-56. PubMed ID: 17639041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Group IIA phospholipase A as a prognostic marker in prostate cancer: relevance to clinicopathological variables and disease-specific mortality.
    Mirtti T; Laine VJ; Hiekkanen H; Hurme S; Rowe O; Nevalainen TJ; Kallajoki M; Alanen K
    APMIS; 2009 Mar; 117(3):151-61. PubMed ID: 19245588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rac subfamily expression and activity in gastrointestinal cancer cell lines].
    Pan YL; Bi F; Liu N; Du JP; Jiang HP; Xue Y; Fan DM
    Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):441-4. PubMed ID: 14575565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of Tiam1 protein expression in prostate carcinomas.
    Engers R; Mueller M; Walter A; Collard JG; Willers R; Gabbert HE
    Br J Cancer; 2006 Oct; 95(8):1081-6. PubMed ID: 17003780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy.
    Huang SP; Huang CY; Wang JS; Liu CC; Pu YS; Yu HJ; Yu CC; Wu TT; Huang CH; Wu WJ; Chou YH; Wu MT
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6632-8. PubMed ID: 18006764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence.
    Seligson DB; Hongo F; Huerta-Yepez S; Mizutani Y; Miki T; Yu H; Horvath S; Chia D; Goodglick L; Bonavida B
    Clin Cancer Res; 2007 Oct; 13(20):6056-63. PubMed ID: 17947468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of MMP-2 expression in prostate cancer: an immunohistochemical study.
    Trudel D; Fradet Y; Meyer F; Harel F; Têtu B
    Cancer Res; 2003 Dec; 63(23):8511-5. PubMed ID: 14679018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher tumor to benign ratio of the androgen receptor mRNA expression associates with prostate cancer progression after radical prostatectomy.
    Rosner IL; Ravindranath L; Furusato B; Chen Y; Gao C; Cullen J; Sesterhenn IA; McLeod DG; Srivastava S; Petrovics G
    Urology; 2007 Dec; 70(6):1225-9. PubMed ID: 18158066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic relevance of annexin A3 in prostate cancer.
    Köllermann J; Schlomm T; Bang H; Schwall GP; von Eichel-Streiber C; Simon R; Schostak M; Huland H; Berg W; Sauter G; Klocker H; Schrattenholz A
    Eur Urol; 2008 Dec; 54(6):1314-23. PubMed ID: 18222597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rac1 and Rac3 have opposing functions in cell adhesion and differentiation of neuronal cells.
    Hajdo-Milasinović A; Ellenbroek SI; van Es S; van der Vaart B; Collard JG
    J Cell Sci; 2007 Feb; 120(Pt 4):555-66. PubMed ID: 17244648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are positive surgical margins in radical prostatectomy specimens an independent prognostic marker?
    Saether T; Sørlien LT; Viset T; Lydersen S; Angelsen A
    Scand J Urol Nephrol; 2008; 42(6):514-21. PubMed ID: 18752153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades.
    Weichert W; Schmidt M; Gekeler V; Denkert C; Stephan C; Jung K; Loening S; Dietel M; Kristiansen G
    Prostate; 2004 Aug; 60(3):240-5. PubMed ID: 15176053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate stem cell antigen (PSCA) mRNA expression in prostatic intraepithelial neoplasia: implications for the development of prostate cancer.
    Zhigang Z; Wenlu S
    Prostate; 2007 Aug; 67(11):1143-51. PubMed ID: 17503471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy.
    Pierorazio PM; Lambert SM; Matsukhani M; Sprenkle PC; McCann TR; Katz AE; Olsson CA; Benson MC; McKiernan JM
    BJU Int; 2007 Nov; 100(5):1066-70. PubMed ID: 17784880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of preoperative serum cell-free circulating DNA in men with prostate cancer undergoing radical prostatectomy.
    Bastian PJ; Palapattu GS; Yegnasubramanian S; Lin X; Rogers CG; Mangold LA; Trock B; Eisenberger M; Partin AW; Nelson WG
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5361-7. PubMed ID: 17875764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression.
    Fixemer T; Wissenbach U; Flockerzi V; Bonkhoff H
    Oncogene; 2003 Oct; 22(49):7858-61. PubMed ID: 14586412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy.
    Roth TJ; Sheinin Y; Lohse CM; Kuntz SM; Frigola X; Inman BA; Krambeck AE; McKenney ME; Karnes RJ; Blute ML; Cheville JC; Sebo TJ; Kwon ED
    Cancer Res; 2007 Aug; 67(16):7893-900. PubMed ID: 17686830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.
    Fleischmann A; Schlomm T; Huland H; Köllermann J; Simon P; Mirlacher M; Salomon G; Chun FH; Steuber T; Simon R; Sauter G; Graefen M; Erbersdobler A
    Clin Cancer Res; 2008 Dec; 14(23):7838-42. PubMed ID: 19047112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase-plasminogen-activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer.
    Thomas C; Wiesner C; Melchior SW; Schmidt F; Gillitzer R; Thüroff JW; Pfitzenmaier J
    BJU Int; 2009 Jul; 104(1):29-34. PubMed ID: 19154451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis.
    Fleischmann A; Schlomm T; Köllermann J; Sekulic N; Huland H; Mirlacher M; Sauter G; Simon R; Erbersdobler A
    Prostate; 2009 Jun; 69(9):976-81. PubMed ID: 19274666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.